Background: The immunomodulatory activity of macrophages was shown to be a
crucial mechanism in the pathogenesis of asthma.
Methods: Induced sputum (IS) and methacholine challenge (MC) were carried o
ut in 21 atopic subjects. Suppressive activity (SA) of sputum macrophages (
SMO) was investigated on autologous peripheral lymphocytes (APL) proliferat
ion in 12 of these patients and compared to the MC.
Results: In 10 of the 21 patients, the FEV1 was >80%; five of these had a n
onreactive MC. Eosinophils and metachromatic cells correlated well (r = 0.6
442; P = 0.0029), but not with the MC. The SA of SMO correlated (P = 0.0152
) with the MC: SMO enhanced APL proliferation in five patients with a posit
ive MC, while SMO showed SA in five with a negative MC. Only two patients w
ith suppressive SMO had a positive MC. Cytokine profiles from five patients
showed that two patients with a negative MC had interleukin (IL)-1 alpha a
nd beta, IL-6, and transforming growth factor (TGF)-beta transcripts, while
two patients with a positive MC transcripted IL-4 and IL-5. One patient wi
th a borderline MC transcripted IL-5, but not IL-4.
Conclusions: These data support the theory that patients with reduced suppr
essive bronchial macrophages display clinical bronchial hyperreactivity.